Webinar - How Does Parkinson’s Disease Begin? Neuroanatomical Pathways, Prions and Histology.

The panel discuss the paper 'How Does Parkinson’s Disease Begin? Perspectives on Neuroanatomical Pathways, Prions, and Histology' by Professor Per Borghammer Read more
Webinar - 'Does Exenatide reduce Non-motor Symptoms in Parkinson’s?'

Professor Brundin is joined by Professor Tom Foltynie who led the exenatide trial... Read more
Webinar - Sleep and Parkinson’s Disease

Professor Patrik Brundin is joined by a panel of experts discussing ‘Sleep and Parkinson’s Disease’. Read more
Webinar - Targeting the Genetics of Parkinson's

Professor Patrik Brundin leads a panel discussing the genetics of Parkinson's... Read more

Webinars

Our informative webinars are in partnership with the Journal of Parkinson’s Disease and Parkinson’s Movement.

These quarterly webinars are each chaired by Professor Patrick Brundin (Van Andel Research Institute) who is joined by a different panel of experts discussing important topics and related research within the Parkinson's community.

Re-watch the webinars here...

Webinar - How Does Parkinson’s Disease Begin? Neuroanatomical Pathways, Prions and Histology.

The panel discuss the paper 'How Does Parkinson’s Disease Begin? Perspectives on Neuroanatomical Pathways, Prions, and Histology' by Professor Per Borghammer Read more

Webinar - 'Does Exenatide reduce Non-motor Symptoms in Parkinson’s?'

Professor Brundin is joined by Professor Tom Foltynie who led the exenatide trial... Read more

Webinar - Sleep and Parkinson’s Disease

Professor Patrik Brundin is joined by a panel of experts discussing ‘Sleep and Parkinson’s Disease’. Read more

Webinar - Targeting the Genetics of Parkinson's

Professor Patrik Brundin leads a panel discussing the genetics of Parkinson's... Read more

Webinar - Stem Cell (Cell Replacement) Therapy

This webinar focuses on developments in the field of stem cell therapy for Parkinson's... Read more

Latest

Award Winner 2019 - Dr Tilo Kunath

Now in its third year, Dr Tilo Kunath is the winner of this year's Tom Isaacs Award...
Emma Green’s Thames Rowing Challenge for CPT

Supporter Emma Green recently completed a fantastic three-day rowing challenge following the length of the Thames to raise funds and awareness for CPT. Here Emma shares her story...
The Linked Clinical Trials Meeting 2019

The 2019 international Linked Clinical Trials meeting is being held this week in Grand Rapids, Michigan - this annual event is an important date in our calendar and heralds the process by which we are bringing much needed novel therapies for the Parkinson's into clinical trial as quickly as possible...
The Grand Garden Fete

On Sunday 11th August supporters Lizzy Pope and Sue O’Reilly held a wonderful Grand Garden Fete in Lizzy’s beautiful garden in Aylesbury in support of The Cure Parkinson’s Trust.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
The Grouse & Grape Luncheon

The Grouse and Grape Luncheon will return to Spencer House on the 8th October 2019 where over 300 guests will be welcomed to take part in this flourishing networking event, all in the aid of The Cure Parkinson's Trust.